Legislative Activity

This bill, the Pharmacists Fight Back in Federal Employee Health Benefit Plans Act, establishes new rules for Pharmacy Benefit Managers (PBMs) administering prescription drug benefits for federal employees. It mandates specific reimbursement rates for pharmacies and prohibits PBMs from engaging in anti-competitive practices like steering patients to affiliated pharmacies. The legislation also institutes civil monetary penalties and potential debarment for PBMs that fail to comply with these new requirements.

This bill establishes new federal requirements for Pharmacy Benefit Managers (PBMs) contracting with Medicare Part D and Medicaid plans, effective in 2027. It mandates specific payment standards for pharmacies, requires PBMs to pass manufacturer rebates directly to patients and plan sponsors, and strictly prohibits steering patients toward specific pharmacies. Additionally, the legislation enhances transparency by expanding drug price reporting requirements for all types of pharmacies within the Medicaid program.

This concurrent resolution commends state and local governments for championing reproductive rights as human rights following the overturning of *Roe v. Wade*. It declares that denying abortion care leads to severe health risks and highlights the criminalization of pregnancy outcomes across the U.S. The resolution urges states to repeal abortion restrictions and affirm that reproductive rights are fundamental human rights.

This bill officially designates the United States Postal Service facility located at 130 South Patterson Avenue in Santa Barbara, California, as the **Brigadier General Frederick R. Lopez Post Office Building**. This change ensures all federal records and documents will use the new name for this specific post office.

This Act officially names the memorial at the entrance to Arlington National Cemetery as the "World War II Women's Memorial." It also designates this memorial as a "commemorative work" under existing federal law. Furthermore, the bill allows a specific World War II home front women's commemorative work to be placed in designated areas within Washington, D.C., overriding standard location restrictions.

The Freedom to Heal Act of 2025 establishes a special registration process for physicians to administer certain unapproved, experimental Schedule I investigational drugs to terminally ill patients under existing "Right to Try" laws. This process, overseen by the Attorney General, requires physicians to meet specific criteria regarding state compliance, manufacturer agreements, and drug handling to prevent diversion. The Act mandates a swift approval timeline for these applications, enabling terminally ill patients greater access to promising treatments.

The ROBINHOOD Act establishes a new 20 percent excise tax on certain secured business loans and lines of credit exceeding $400,000 in adjusted gross income. This tax applies when the loan is secured by capital assets, excluding residential mortgages and farmland loans. The borrower is responsible for paying this annual tax to the Treasury.

This resolution designates December 8, 2025, as "Jimmy Lai Day" to honor his advocacy for press freedom, religious freedom, and democracy in Hong Kong. It condemns the actions of the People's Republic of China and Hong Kong authorities for suppressing fundamental freedoms and calls for the immediate release of Jimmy Lai and all unjustly imprisoned pro-democracy advocates.

The Weatherization Enhancement and Readiness Act of 2025 significantly increases funding authorization for the Weatherization Assistance Program through 2030. This bill also raises the maximum average cost allowed for weatherizing a single home from $6,500 to $12,000. Finally, it mandates that the Department of Energy's annual readiness report to Congress include details on how enhancement efforts impact program eligibility.

The Independence Investment Fund Act establishes a $\$5$ billion Treasury-managed fund to make equity and debt investments in U.S. companies developing critical and emerging technologies. This initiative aims to strengthen national security by countering adversarial foreign investments, particularly in sectors like biotechnology. The Fund will operate for 10 years under the oversight of an independent managing entity and requires regular reporting to Congress on its performance and objectives.

The Dignity for Detained Immigrants Act aims to overhaul immigration detention by establishing mandatory, high standards based on ABA guidelines and increasing transparency through rigorous, unannounced inspections. The bill prohibits the use of private, for-profit detention facilities within three years and ends the mandatory detention of most noncitizens, prioritizing release or community-based alternatives. Furthermore, it establishes new due process rights, including timely custody hearings, a presumption of release, and prohibitions on detaining children or using solitary confinement.

The Mikaela Naylon Give Kids a Chance Act focuses primarily on improving pediatric drug development and ensuring patient access to necessary treatments. This legislation mandates new research requirements for molecularly targeted pediatric cancer drugs, strengthens FDA enforcement of pediatric study completion, and extends incentives for developing drugs for rare pediatric diseases. Additionally, the bill updates organ transplant network functions and establishes an Abraham Accords Office within the FDA to enhance international regulatory cooperation.

This resolution supports the goals of Transgender Day of Remembrance by recognizing the ongoing epidemic of violence targeting transgender people, particularly transgender women of color. It memorializes the lives lost this year and highlights the systemic barriers, including discrimination and lack of healthcare access, faced by the transgender community. The bill calls for urgent action from the government to protect these lives through inclusive legislation and policies that ensure dignity and respect for all individuals.

The End Child Poverty Act establishes a universal monthly cash assistance program for qualifying children, administered by a new office within the Social Security Administration. This act terminates the Child Tax Credit and Earned Income Tax Credit after 2025, replacing them with direct child payments. Additionally, the bill introduces new refundable tax credits for taxpayers supporting adult dependents and for low-to-middle income adults and families.

The BOOST Act of 2025 establishes a universal adult assistance program providing qualifying U.S. residents aged 19 to 67 with a monthly cash payment of $250, administered by the Social Security Administration. To fund this, the bill simultaneously imposes a new federal income tax of 2.5% on adjusted gross income exceeding $30,000 for individuals or $60,000 for joint filers. These assistance payments are explicitly excluded from being counted as income for federal benefit or tax purposes.

The Baby Bonus Act establishes a new federal program within the Social Security Administration to provide a one-time financial payment to eligible parents of newborn children, beginning in 2026. This benefit is designed to be non-taxable and protected from being counted as a resource for federal benefit programs. The legislation creates the Office of Baby Assistance to manage the application and payment process for this new benefit.

The Urban and Rural Diabetes Initiative Act establishes a new grant program to improve diabetes treatment access in medically underserved urban and rural areas. This funding supports eligible health providers in offering comprehensive diabetes care, including routine treatment, education, and specialized services like eye and foot care. The Secretary of Health and Human Services will award these grants, ensuring equitable distribution across both urban and rural communities.

The EXPERTS Act of 2025 aims to enhance transparency and accountability in the federal rulemaking process. It introduces new disclosure requirements for studies submitted during public comment periods and mandates greater public awareness of agency actions. Furthermore, the bill establishes the Office of the Public Advocate to improve public involvement and explicitly requires agencies to consider social equity in their cost-benefit analyses. Finally, it streamlines the Office of Information and Regulatory Affairs (OIRA) review timeline and clarifies judicial review standards for agency interpretations.

The Alzheimer’s Screening and Prevention Act of 2025 (ASAP Act) amends Medicare to cover early detection screening tests for Alzheimer's disease and related dementias starting in 2028. This coverage applies to FDA-cleared tests, including genomic sequencing and other equivalent diagnostic methods, designed to detect pre-symptomatic or early-stage conditions. The bill ensures these screenings are added to the list of covered medical services under Medicare.

The Global Respect Act aims to promote and protect the human rights of LGBTQI individuals worldwide. It mandates the President to identify and report foreign persons responsible for human rights violations against LGBTQI people, leading to their inadmissibility to the United States. Furthermore, the Act requires enhanced tracking and reporting of violence and discrimination targeting individuals based on sexual orientation, gender identity, or sex characteristics in the annual human rights reports.